MeiraGTx Holdings plc - Ordinary Shares (MGTX) earnings
MGTX earnings moved a median of -0.30% by the close. Quarterly and annual MGTX reports and results, each read against the price at its own news timestamp. Back to the MGTX overview →
21 measured MGTX earnings events.
Where these MGTX earnings landedvs 19 measured MGTX earnings reactions
| Middle 50% of MGTX earnings reactions | -6.98% to +2.19% |
|---|---|
| Median reaction (to close) | -0.30% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 MGTX earnings events with a measured close landed between -6.98% and +2.19%; 32% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q MeiraGTx Holdings plc For: Jun 30 | SEC filing · Form 10-Q | -2.61% | -10.71% | |
| MeiraGTx Reports Second Quarter 2026 Financial and Operational Results | Press release | -2.61% | -10.71% | |
| Form 10-Q MeiraGTx Holdings plc For: Mar 31 | SEC filing · Form 10-Q | -1.40% | -0.30% | |
| MeiraGTx Reports First Quarter 2026 Financial and Operational Results | Press release | -1.40% | -0.30% | |
| Form 10-K MeiraGTx Holdings plc For: Dec 31 | SEC filing · Form 10-K | -2.16% | +9.32% | |
| Form 10-Q MeiraGTx Holdings plc For: Sep 30 | SEC filing · Form 10-Q | +1.63% | — | |
| MeiraGTx Reports Third Quarter 2025 Financial and Operational Results | Press release | +1.63% | — | |
| Form 10-Q MeiraGTx Holdings plc For: Jun 30 | SEC filing · Form 10-Q | -0.29% | -3.03% | |
| MeiraGTx Reports Second Quarter 2025 Financial and Operational Results | Press release | -1.36% | +1.71% | |
| Form 10-Q MeiraGTx Holdings plc For: Mar 31 | SEC filing · Form 10-Q | +0.62% | -8.20% | |
| MeiraGTx Reports First Quarter 2025 Financial and Operational Results | Press release | +0.62% | -8.20% | |
| Form 10-K MeiraGTx Holdings plc For: Dec 31 | SEC filing · Form 10-K | +1.25% | +2.68% | |
| Form 10-Q MeiraGTx Holdings plc For: Sep 30 | SEC filing · Form 10-Q | +5.07% | +3.38% | |
| MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates | Press release | +5.07% | +3.38% | |
| Form 10-Q MeiraGTx Holdings plc For: Jun 30 | SEC filing · Form 10-Q | -5.81% | -6.98% | |
| MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results | Press release | -5.81% | -6.98% | |
| Form 10-Q MeiraGTx Holdings plc For: Mar 31 | SEC filing · Form 10-Q | +4.12% | +0.00% | |
| MeiraGTx Reports First Quarter 2024 Financial and Operational Results | Press release | +4.12% | +0.00% | |
| Form 10-K MeiraGTx Holdings plc For: Dec 31 | SEC filing · Form 10-K | +1.38% | +9.29% | |
| Form 10-Q MeiraGTx Holdings plc For: Sep 30 | SEC filing · Form 10-Q | -1.43% | -1.22% | |
| MeiraGTx Announces Third Quarter 2023 Financial and Operational Results | Press release | -1.43% | -1.22% |
Keep exploring
More MGTX: analyst actions → · SEC filings → · MGTX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | 239 | 0.00% | 41% |
| Lixte Biotechnology Holdings, Inc. (LIXT) | 239 | 0.00% | 48% |
| Ovid Therapeutics Inc. (OVID) | 239 | -0.32% | 40% |
| Cyclacel Pharmaceuticals, Inc. (CYCC) | 238 | -0.21% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.